Effector and regulatory mechanisms in allergic contact dermatitis

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 64, Issue 12, 2009, Pages 1699-1714

  Vocanson, M ^a,b,c   Hennino, A ^a,c   Rozieres A ^a,c   Poyet, G ^a,c   Nicolas, J F ^a,b,c,d  

^a University Lyon i   (France)

^b UNIVERSITÉ LYON 1   (France)

^c UNIVERSITÉ DE LYON   (France)

^d HOSPICES CIVILS DE LYON   (France)

Author keywords

Allergic contact dermatitis; CD4+ regulatory T cells; CD8+ effector T cells; Haptens; Mast cells

Indexed keywords

1 CHLORO 2,4 DINITROBENZENE; ACEBUTOLOL; BENZENE DERIVATIVE; CD19 ANTIGEN; CINNAMALDEHYDE; CONTACT ALLERGEN; CUTANEOUS T CELL ATTRACTING CHEMOKINE; DYE; ETHYLENEDIAMINE; EUGENOL; GAMMA INTERFERON; HAPTEN; HYDROCORTISONE; INTERCELLULAR ADHESION MOLECULE 1; MONOCLONAL ANTIBODY; OXAZOLONE; STYRENE; SULFAMETHOXAZOLE; TERPINENE;

B LYMPHOCYTE; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL POLARITY; CONTACT ALLERGY; DOWN REGULATION; ECZEMA; ENVIRONMENTAL EXPOSURE; GRANULOCYTE; HUMAN; IMMUNOLOGICAL TOLERANCE; INNATE IMMUNITY; LANGERHANS CELL; LYMPHOID ORGAN; MAST CELL; MEMORY T LYMPHOCYTE; NATURAL KILLER CELL; OCCUPATIONAL DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REGULATORY MECHANISM; REGULATORY T LYMPHOCYTE; REVIEW; SKIN ALLERGY; SKIN INFLAMMATION; SKIN SENSITIZATION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

EID: 70449133956     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2009.02082.x     Document Type: Review

References (159)

1. Coenraads PJ, Goncalo M. Skin diseases with high public health impact. Contact dermatitis. Eur J Dermatol 2007 17 : 564 565.
2. Saint-Mezard P, Rosieres A, Krasteva M, Berard F, Dubois B, Kaiserlian D et al. Allergic contact dermatitis. Eur J Dermatol 2004 14 : 284 295.
3. Asano Y, Makino T, Norisugi O, Shimizu T. Occupational cobalt induced systemic contact dermatitis. Eur J Dermatol 2008 19 : 166 167.
4. Nicolas JF, Testud F, Vocanson M. Sensitisation versus tolerance in contact eczema. Ann Dermatol Venereol 2008 135 : 733 736.
5. Belsito DV. The diagnostic evaluation, treatment, and prevention of allergic contact dermatitis in the new millennium. J Allergy Clin Immunol 2000 105 : 409 420.
6. Blauvelt A, Hwang ST, Udey MC. 11. Allergic and immunologic diseases of the skin. J Allergy Clin Immunol 2003 111 (2 SUPPL. S560 S570.
7. Lepoittevin J, Leblond I. Hapten-peptide T cell receptor interactions: molecular basis for the recognition of haptens by T lymphocytes. Eur J Dermatol 1997 7 : 151 154.
8. Divkovic M, Pease CK, Gerberick GF, Basketter DA. Hapten-protein binding: from theory to practical application in the in vitro prediction of skin sensitization. Contact Dermatitis 2005 53 : 189 200.
9. Benezra C. Molecular aspects of allergic contact dermatitis. Acta Derm Venereol Suppl (Stockh) 1987 134 : 62 63.
10. Karlberg AT, Bergstrom MA, Borje A, Luthman K, Nilsson JL. Allergic contact dermatitis - formation, structural requirements, and reactivity of skin sensitizers. Chem Res Toxicol 2008 21 : 53 69.
11. Zhang Y, Wilcox DE. Thermodynamic and spectroscopic study of Cu(II) and Ni(II) binding to bovine serum albumin. J Biol Inorg Chem 2002 7 : 327 337.
12. Pichler WJ, Beeler A, Keller M, Lerch M, Posadas S, Schmid D et al. Pharmacological interaction of drugs with immune receptors: the p-i concept. Allergol Int 2006 55 : 17 25.
13. Lepoittevin JP. Metabolism versus chemical transformation or pro- versus prehaptens? Contact Dermatitis 2006 54 : 73 74.
14. Griem P, Wulferink M, Sachs B, Gonzalez JB, Gleichmann E. Allergic and autoimmune reactions to xenobiotics: how do they arise? Immunol Today 1998 19 : 133 141.
15. Hagvall L, Backtorp C, Svensson S, Nyman G, Borje A, Karlberg AT. Fragrance compound geraniol forms contact allergens on air exposure. Identification and quantification of oxidation products and effect on skin sensitization. Chem Res Toxicol 2007 20 : 807 814.
16. Matura M, Skold M, Borje A, Andersen KE, Bruze M, Frosch P et al. Selected oxidized fragrance terpenes are common contact allergens. Contact Dermatitis 2005 52 : 320 328.
17. Skold M, Borje A, Harambasic E, Karlberg AT. Contact allergens formed on air exposure of linalool. Identification and quantification of primary and secondary oxidation products and the effect on skin sensitization. Chem Res Toxicol 2004 17 : 1697 1705.
18. Avenel-Audran M. Photoallergic dermatitis. Allergy Immunol (Paris) 1999 31 : 217 220.
19. Merk HF, Baron JM, Neis MM, Obrigkeit DH, Karlberg AT. Skin: major target organ of allergic reactions to small molecular weight compounds. Toxicol Appl Pharmacol 2007 224 : 313 317.
20. Martin SF, Dudda JC, Bachtanian E, Lembo A, Liller S, Durr C et al. Toll-like receptor and IL-12 signaling control susceptibility to contact hypersensitivity. J Exp Med 2008 205 : 2151 2162.
21. Martin SF, Jakob T. From innate to adaptive immune responses in contact hypersensitivity. Curr Opin Allergy Clin Immunol 2008 8 : 289 293.
22. Jakob T, Ring J, Udey MC. Multistep navigation of Langerhans/dendritic cells in and out of the skin. J Allergy Clin Immunol 2001 108 : 688 696.
23. Furio L, Guezennec A, Ducarre B, Guesnet J, Peguet-Navarro J. Differential effects of allergens and irritants on early differentiating monocyte-derived dendritic cells. Eur J Dermatol 2008 18 : 141 147.
24. Weltzien HU, Moulon C, Martin S, Padovan E, Hartmann U, Kohler J. T cell immune responses to haptens. Structural models for allergic and autoimmune reactions. Toxicology 1996 107 : 141 151.
25. Xu H, DiIulio NA, Fairchild RL. T cell populations primed by hapten sensitization in contact sensitivity are distinguished by polarized patterns of cytokine production: interferon gamma-producing (Tc1) effector CD8+ T cells and interleukin (Il) 4/Il-10-producing (Th2) negative regulatory CD4+ T cells. J Exp Med 1996 183 : 1001 1012.
26. Saint-Mezard P, Krasteva M, Chavagnac C, Bosset S, Akiba H, Kehren J et al. Afferent and efferent phases of allergic contact dermatitis (ACD) can be induced after a single skin contact with haptens: evidence using a mouse model of primary ACD. J Invest Dermatol 2003 120 : 641 647.
27. Akiba H, Kehren J, Ducluzeau MT, Krasteva M, Horand F, Kaiserlian D et al. Skin inflammation during contact hypersensitivity is mediated by early recruitment of CD8+ T cytotoxic 1 cells inducing keratinocyte apoptosis. J Immunol 2002 168 : 3079 3087.
28. Kehren J, Desvignes C, Krasteva M, Ducluzeau MT, Assossou O, Horand F et al. Cytotoxicity is mandatory for CD8(+) T cell-mediated contact hypersensitivity. J Exp Med 1999 189 : 779 786.
29. Bour H, Peyron E, Gaucherand M, Garrigue JL, Desvignes C, Kaiserlian D et al. Major histocompatibility complex class I-restricted CD8+ T cells and class II-restricted CD4+ T cells, respectively, mediate and regulate contact sensitivity to dinitrofluorobenzene. Eur J Immunol 1995 25 : 3006 3010.
30. Kish DD, Gorbachev AV, Fairchild RL. CD8+ T cells produce IL-2, which is required for CD(4+)CD25+ T cell regulation of effector CD8+ T cell development for contact hypersensitivity responses. J Leukoc Biol 2005 78 : 725 735.
31. Dubois B, Chapat L, Goubier A, Kaiserlian D. CD4+CD25+ T cells as key regulators of immune responses. Eur J Dermatol 2003 13 : 111 116.
32. Saint-Mezard P, Berard F, Dubois B, Kaiserlian D, Nicolas JF. The role of CD4+ and CD8+ T cells in contact hypersensitivity and allergic contact dermatitis. Eur J Dermatol 2004 14 : 131 138.
33. Buckley DA, Rycroft RJ, White IR, McFadden JP. Fragrance as an occupational allergen. Occup Med (Lond) 2002 52 : 13 16.
34. Vocanson M, Hennino A, Cluzel-Tailhardat M, Saint-Mezard P, Benetiere J, Chavagnac C et al. CD8+ T cells are effector cells of contact dermatitis to common skin allergens in mice. J Invest Dermatol 2006 126 : 815 820.
35. Zaba LC, Krueger JG, Lowes MA. Resident and "inflammatory" dendritic cells in human skin. J Invest Dermatol 2009 129 : 302 308.
36. Kaplan DH, Kissenpfennig A, Clausen BE. Insights into Langerhans cell function from Langerhans cell ablation models. Eur J Immunol 2008 38 : 2369 2376.
37. Bonneville M, Chavagnac C, Vocanson M, Rozieres A, Benetiere J, Pernet I et al. Skin contact irritation conditions the development and severity of allergic contact dermatitis. J Invest Dermatol 2007 127 : 1430 1435.
38. Aiba S. Dendritic cells: importance in allergy. Allergol Int 2007 56 : 201 208.
39. Kissenpfennig A, Malissen B. Langerhans cells - revisiting the paradigm using genetically engineered mice. Trends Immunol 2006 27 : 132 139.
40. Villadangos JA, Heath WR. Life cycle, migration and antigen presenting functions of spleen and lymph node dendritic cells: limitations of the Langerhans cells paradigm. Semin Immunol 2005 17 : 262 272.
41. Sabatte J, Maggini J, Nahmod K, Amaral MM, Martinez D, Salamone G et al. Interplay of pathogens, cytokines and other stress signals in the regulation of dendritic cell function. Cytokine Growth Factor Rev 2007 18 : 5 17.
42. Cumberbatch M, Dearman RJ, Griffiths CE, Kimber I. Epidermal Langerhans cell migration and sensitisation to chemical allergens. Apmis 2003 111 : 797 804.
43. Le Borgne M, Etchart N, Goubier A, Lira SA, Sirard JC, van Rooijen N et al. Dendritic cells rapidly recruited into epithelial tissues via CCR6/CCL20 are responsible for CD8+ T cell crosspriming in vivo. Immunity 2006 24 : 191 201.
44. Villadangos JA. Hold on, the monocytes are coming Immunity 2007 26 : 390 392.
45. Ginhoux F, Collin MP, Bogunovic M, Abel M, Leboeuf M, Helft J et al. Blood-derived dermal langerin+ dendritic cells survey the skin in the steady state. J Exp Med 2007 204 : 3133 3146.
46. Bursch LS, Wang L, Igyarto B, Kissenpfennig A, Malissen B, Kaplan DH et al. Identification of a novel population of Langerin+ dendritic cells. J Exp Med 2007 204 : 3147 3156.
47. Poulin LF, Henri S, de Bovis B, Devilard E, Kissenpfennig A, Malissen B. The dermis contains langerin+ dendritic cells that develop and function independently of epidermal Langerhans cells. J Exp Med 2007 204 : 3119 3131.
48. Wang L, Bursch LS, Kissenpfennig A, Malissen B, Jameson SC, Hogquist KA. Langerin expressing cells promote skin immune responses under defined conditions. J Immunol 2008 180 : 4722 4727.
49. Fukunaga A, Khaskhely NM, Sreevidya CS, Byrne SN, Ullrich SE. Dermal dendritic cells, and not Langerhans cells, play an essential role in inducing an immune response. J Immunol 2008 180 : 3057 3064.
50. McMinn PC, Halliday GM, Muller HK. Effects of gliotoxin on Langerhans' cell function: contact hypersensitivity responses and skin graft survival. Immunology 1990 71 : 46 51.
51. Lynch DH, Gurish MF, Daynes RA. Relationship between epidermal Langerhans cell density ATPase activity and the induction of contact hypersensitivity. J Immunol 1981 126 : 1892 1897.
52. Ptak W, Rozycka D, Askenase PW, Gershon RK. Role of antigen-presenting cells in the development and persistence of contact hypersensitivity. J Exp Med 1980 151 : 362 375.
53. Tamaki K, Fujiwara H, Levy RB, Shearer GM, Katz SI. Hapten specific TNP-reactive cytotoxic effector cells using epidermal cells as targets. J Invest Dermatol 1981 77 : 225 229.
54. Girolomoni G, Lutz MB, Pastore S, Assmann CU, Cavani A, Ricciardi-Castagnoli P. Establishment of a cell line with features of early dendritic cell precursors from fetal mouse skin. Eur J Immunol 1995 25 : 2163 2169.
55. Grabbe S, Steinbrink K, Steinert M, Luger TA, Schwarz T. Removal of the majority of epidermal Langerhans cells by topical or systemic steroid application enhances the effector phase of murine contact hypersensitivity. J Immunol 1995 155 : 4207 4217.
56. Kissenpfennig A, Henri S, Dubois B, Laplace-Builhe C, Perrin P, Romani N et al. Dynamics and function of Langerhans cells in vivo: dermal dendritic cells colonize lymph node areas distinct from slower migrating Langerhans cells. Immunity 2005 22 : 643 654.
57. Bennett CL, van Rijn E, Jung S, Inaba K, Steinman RM, Kapsenberg ML et al. Inducible ablation of mouse Langerhans cells diminishes but fails to abrogate contact hypersensitivity. J Cell Biol 2005 169 : 569 576.
58. Kaplan DH, Jenison MC, Saeland S, Shlomchik WD, Shlomchik MJ. Epidermal langerhans cell-deficient mice develop enhanced contact hypersensitivity. Immunity 2005 23 : 611 620.
59. Allan RS, Waithman J, Bedoui S, Jones CM, Villadangos JA, Zhan Y et al. Migratory dendritic cells transfer antigen to a lymph node-resident dendritic cell population for efficient CTL priming. Immunity 2006 25 : 153 162.
60. Martin S, Ortmann B, Pflugfelder U, Birsner U, Weltzien HU. Role of hapten-anchoring peptides in defining hapten-epitopes for MHC-restricted cytotoxic T cells. Cross-reactive TNP-determinants on different peptides. J Immunol 1992 149 : 2569 2575.
61. von Bonin A, Ortmann B, Martin S, Weltzien HU. Peptide-conjugated hapten groups are the major antigenic determinants for trinitrophenyl-specific cytotoxic T cells. Int Immunol 1992 4 : 869 874.
62. Kohler J, Hartmann U, Grimm R, Pflugfelder U, Weltzien HU. Carrier-independent hapten recognition and promiscuous MHC restriction by CD4 T cells induced by trinitrophenylated peptides. J Immunol 1997 158 : 591 597.
63. Cavani A, Hackett CJ, Wilson KJ, Rothbard JB, Katz SI. Characterization of epitopes recognized by hapten-specific CD4+ T cells. J Immunol 1995 154 : 1232 1238.
64. Martin S, von Bonin A, Fessler C, Pflugfelder U, Weltzien HU. Structural complexity of antigenic determinants for class I MHC-restricted, hapten-specific T cells. Two qualitatively differing types of H-2Kb-restricted TNP epitopes. J Immunol 1993 151 : 678 687.
65. Martin S, Lappin MB, Kohler J, Delattre V, Leicht C, Preckel T et al. Peptide immunization indicates that CD8+ T cells are the dominant effector cells in trinitrophenyl-specific contact hypersensitivity. J Invest Dermatol 2000 115 : 260 266.
66. Gamerdinger K, Moulon C, Karp DR, Van Bergen J, Koning F, Wild D et al. A new type of metal recognition by human T cells: contact residues for peptide-independent bridging of T cell receptor and major histocompatibility complex by nickel. J Exp Med 2003 197 : 1345 1353.
67. Wulferink M, Dierkes S, Gleichmann E. Cross-sensitization to haptens: formation of common haptenic metabolites, T cell recognition of cryptic peptides, and true T cell cross-reactivity. Eur J Immunol 2002 32 : 1338 1348.
68. Greenwald RJ, Freeman GJ, Sharpe AH. The B7 family revisited. Annu Rev Immunol 2005 23 : 515 548.
69. Reiser H, Schneeberger EE. Expression and function of B7-1 and B7-2 in hapten-induced contact sensitivity. Eur J Immunol 1996 26 : 880 885.
70. Symington FW, Brady W, Linsley PS. Expression and function of B7 on human epidermal Langerhans cells. J Immunol 1993 150 : 1286 1295.
71. Kondo S, Kooshesh F, Wang B, Fujisawa H, Sauder DN. Contribution of the CD28 molecule to allergic and irritant-induced skin reactions in CD28-/- mice. J Immunol 1996 157 : 4822 4829.
72. Xu H, Banerjee A, Dilulio NA, Fairchild RL. Development of effector CD8+ T cells in contact hypersensitivity occurs independently of CD4+ T cells. J Immunol 1997 158 : 4721 4728.
73. Chen AI, McAdam AJ, Buhlmann JE, Scott S, Lupher ML Jr., Greenfield EA et al. Ox40-ligand has a critical costimulatory role in dendritic cell: T cell interactions. Immunity 1999 11 : 689 698.
74. Kim HK, Guan H, Zu G, Li H, Wu L, Feng X et al. High-level expression of B7-H1 molecules by dendritic cells suppresses the function of activated T cells and desensitizes allergen-primed animals. J Leukoc Biol 2006 79 : 686 695.
75. Mahnke K, Ring S, Johnson TS, Schallenberg S, Schonfeld K, Storn V et al. Induction of immunosuppressive functions of dendritic cells in vivo by CD4+CD25+ regulatory T cells: role of B7-H3 expression and antigen presentation. Eur J Immunol 2007 37 : 2117 2126.
76. Tsushima F, Iwai H, Otsuki N, Abe M, Hirose S, Yamazaki T et al. Preferential contribution of B7-H1 to programmed death-1-mediated regulation of hapten-specific allergic inflammatory responses. Eur J Immunol 2003 33 : 2773 2782.
77. Li L, Sad S, Kagi D, Mosmann TR. CD8Tc1 and Tc2 cells secrete distinct cytokine patterns in vitro and in vivo but induce similar inflammatory reactions. J Immunol 1997 158 : 4152 4161.
78. Traidl-Hoffmann C, Mariani V, Hochrein H, Karg K, Wagner H, Ring J et al. Pollen-associated phytoprostanes inhibit dendritic cell interleukin-12 production and augment T helper type 2 cell polarization. J Exp Med 2005 201 : 627 636.
79. Wang YH, Liu YJ. OX40-OX40L interactions: a promising therapeutic target for allergic diseases? J Clin Invest 2007 117 : 3655 3657.
80. Jiang A, Bloom O, Ono S, Cui W, Unternaehrer J, Jiang S et al. Disruption of E-cadherin-mediated adhesion induces a functionally distinct pathway of dendritic cell maturation. Immunity 2007 27 : 610 624.
81. Martin S, Delattre V, Leicht C, Weltzien HU, Simon JC. A high frequency of allergen-specific CD8+ Tc1 cells is associated with the murine immune response to the contact sensitizer trinitrophenyl. Exp Dermatol 2003 12 : 78 85.
82. Van Och FM, Van Loveren H, De Jong WH, Vandebriel RJ. Cytokine production induced by low-molecular-weight chemicals as a function of the stimulation index in a modified local lymph node assay: an approach to discriminate contact sensitizers from respiratory sensitizers. Toxicol Appl Pharmacol 2002 184 : 46 56.
83. Larsen JM, Bonefeld CM, Poulsen SS, Geisler C, Skov L. IL-23 and T(H)17-mediated inflammation in human allergic contact dermatitis. J Allergy Clin Immunol 2008 123 : 486 492.
84. He D, Wu L, Kim HK, Li H, Elmets CA, Xu H. CD8+ IL-17-producing T cells are important in effector functions for the elicitation of contact hypersensitivity responses. J Immunol 2006 177 : 6852 6858.
85. Gorbachev AV, DiIulio NA, Fairchild RL. IL-12 augments CD8+ T cell development for contact hypersensitivity responses and circumvents anti-CD154 antibody-mediated inhibition. J Immunol 2001 167 : 156 162.
86. Riemann H, Loser K, Beissert S, Fujita M, Schwarz A, Schwarz T et al. IL-12 breaks dinitrothiocyanobenzene (DNTB)-mediated tolerance and converts the tolerogen DNTB into an immunogen. J Immunol 2005 175 : 5866 5874.
87. Gocinski BL, Tigelaar RE. Roles of CD4+ and CD8+ T cells in murine contact sensitivity revealed by in vivo monoclonal antibody depletion. J Immunol 1990 144 : 4121 4128.
88. Bouloc A, Cavani A, Katz SI. Contact hypersensitivity in MHC class II-deficient mice depends on CD8 T lymphocytes primed by immunostimulating Langerhans cells. J Invest Dermatol 1998 111 : 44 49.
89. Kolesaric A, Stingl G, Elbe-Burger A. MHC class I+/II- dendritic cells induce hapten-specific immune responses in vitro and in vivo. J Invest Dermatol 1997 109 : 580 585.
90. Krasteva M, Kehren J, Horand F, Akiba H, Choquet G, Ducluzeau MT et al. Dual role of dendritic cells in the induction and down-regulation of antigen-specific cutaneous inflammation. J Immunol 1998 160 : 1181 1190.
91. Matzinger P. The danger model: a renewed sense of self. Science 2002 296 : 301 305.
92. Krasteva M, Kehren J, Ducluzeau MT, Sayag M, Cacciapuoti M, Akiba H et al. Contact dermatitis I. Pathophysiology of contact sensitivity. Eur J Dermatol 1999 9 : 65 77.
93. Sallusto F, Lenig D, Forster R, Lipp M, Lanzavecchia A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 1999 401 : 708 712.
94. Walzer T, Marcais A, Saltel F, Bella C, Jurdic P, Marvel J. Cutting edge: immediate RANTES secretion by resting memory CD8 T cells following antigenic stimulation. J Immunol 2003 170 : 1615 1619.
95. Santamaria-Babi LF. CLA(+) T cells in cutaneous diseases. Eur J Dermatol 2004 14 : 13 18.
96. Dudda JC, Simon JC, Martin S. Dendritic cell immunization route determines CD8+ T cell trafficking to inflamed skin: role for tissue microenvironment and dendritic cells in establishment of T cell-homing subsets. J Immunol 2004 172 : 857 863.
97. Mora JR, von Andrian UH. T-cell homing specificity and plasticity: new concepts and future challenges. Trends Immunol 2006 27 : 235 243.
98. Berg EL, Yoshino T, Rott LS, Robinson MK, Warnock RA, Kishimoto TK et al. The cutaneous lymphocyte antigen is a skin lymphocyte homing receptor for the vascular lectin endothelial cell-leukocyte adhesion molecule 1. J Exp Med 1991 174 : 1461 1466.
99. Campbell JJ, Haraldsen G, Pan J, Rottman J, Qin S, Ponath P et al. The chemokine receptor CCR4 in vascular recognition by cutaneous but not intestinal memory T cells. Nature 1999 400 : 776 780.
100. Erdmann I, Scheidegger EP, Koch FK, Heinzerling L, Odermatt B, Burg G et al. Fucosyltransferase VII-deficient mice with defective E-, P-, and L-selectin ligands show impaired CD4+ and CD8+ T cell migration into the skin, but normal extravasation into visceral organs. J Immunol 2002 168 : 2139 2146.
101. Reiss Y, Proudfoot AE, Power CA, Campbell JJ, Butcher EC. CC chemokine receptor (CCR)4 and the CCR10 ligand cutaneous T cell-attracting chemokine (CTACK) in lymphocyte trafficking to inflamed skin. J Exp Med 2001 194 : 1541 1547.
102. Santamaria LF, Perez Soler MT, Hauser C, Blaser K. Allergen specificity and endothelial transmigration of T cells in allergic contact dermatitis and atopic dermatitis are associated with the cutaneous lymphocyte antigen. Int Arch Allergy Immunol 1995 107 : 359 362.
103. Morales J, Homey B, Vicari AP, Hudak S, Oldham E, Hedrick J et al. CTACK, a skin-associated chemokine that preferentially attracts skin-homing memory T cells. Proc Natl Acad Sci USA 1999 96 : 14470 14475.
104. Kerfoot SM, Szczepanik M, Tung JW, Askenase PW. Identification of initiator B cells, a novel subset of activation-induced deaminase-dependent B-1-like cells that mediate initiation of contact sensitivity. J Immunol 2008 181 : 1717 1727.
105. Campos RA, Szczepanik M, Lisbonne M, Itakura A, Leite-de-Moraes M, Askenase PW. Invariant NKT cells rapidly activated via immunization with diverse contact antigens collaborate in vitro with B-1 cells to initiate contact sensitivity. J Immunol 2006 177 : 3686 3694.
106. Campos RA, Szczepanik M, Itakura A, Lisbonne M, Dey N, Leite-de-Moraes MC et al. Interleukin-4-dependent innate collaboration between iNKT cells and B-1 B cells controls adaptative contact sensitivity. Immunology 2006 117 : 536 547.
107. Tsuji RF, Szczepanik M, Kawikova I, Paliwal V, Campos RA, Itakura A et al. B cell-dependent T cell responses: IgM antibodies are required to elicit contact sensitivity. J Exp Med 2002 196 : 1277 1290.
108. Askenase PW, Bursztajn S, Gershon MD, Gershon RK. T cell-dependent mast cell degranulation and release of serotonin in murine delayed-type hypersensitivity. J Exp Med 1980 152 : 1358 1374.
109. Tamagawa-Mineoka R, Katoh N, Ueda E, Takenaka H, Kita M, Kishimoto S. The role of platelets in leukocyte recruitment in chronic contact hypersensitivity induced by repeated elicitation. Am J Pathol 2007 170 : 2019 2029.
110. Tsuji RF, Kawikova I, Ramabhadran R, Akahira-Azuma M, Taub D, Hugli TE et al. Early local generation of C5a initiates the elicitation of contact sensitivity by leading to early T cell recruitment. J Immunol 2000 165 : 1588 1598.
111. Albanesi C, Scarponi C, Sebastiani S, Cavani A, Federici M, Sozzani S et al. A cytokine-to-chemokine axis between T lymphocytes and keratinocytes can favor Th1 cell accumulation in chronic inflammatory skin diseases. J Leukoc Biol 2001 70 : 617 623.
112. Homey B, Steinhoff M, Ruzicka T, Leung DY. Cytokines and chemokines orchestrate atopic skin inflammation. J Allergy Clin Immunol 2006 118 : 178 189. (Pubitemid 43946487)
113. Suzuki K, Okuno T, Yamamoto M, Pasterkamp RJ, Takegahara N, Takamatsu H et al. Semaphorin 7A initiates T-cell-mediated inflammatory responses through alpha 1 beta 1 integrin. Nature 2007 446 : 680 684.
114. Engeman T, Gorbachev AV, Kish DD, Fairchild RL. The intensity of neutrophil infiltration controls the number of antigen-primed CD8 T cells recruited into cutaneous antigen challenge sites. J Leukoc Biol 2004 76 : 941 949.
115. Cattani F, Gallese A, Mosca M, Buanne P, Biordi L, Francavilla S et al. The role of CXCR2 activity in the contact hypersensitivity response in mice. Eur Cytokine Netw 2006 17 : 42 48.
116. Biedermann T, Kneilling M, Mailhammer R, Maier K, Sander CA, Kollias G et al. Mast cells control neutrophil recruitment during T cell-mediated delayed-type hypersensitivity reactions through tumor necrosis factor and macrophage inflammatory protein 2. J Exp Med 2000 192 : 1441 1452.
117. Biedermann T, Mailhammer R, Mai A, Sander C, Ogilvie A, Brombacher F et al. Reversal of established delayed type hypersensitivity reactions following therapy with IL-4 or antigen-specific Th2 cells. Eur J Immunol 2001 31 : 1582 1591.
118. Cher DJ, Mosmann TR. Two types of murine helper T cell clone. II. Delayed-type hypersensitivity is mediated by TH1 clones. J Immunol 1987 138 : 3688 3694.
119. Gawkrodger DJ, Lloyd MH, Hunter JA. Occupational skin disease in hospital cleaning and kitchen workers. Contact Dermatitis 1986 15 : 132 135.
120. Herrick CA, Das J, Xu L, Wisnewski AV, Redlich CA, Bottomly K. Differential roles for CD4 and CD8 T cells after diisocyanate sensitization: genetic control of TH2-induced lung inflammation. J Allergy Clin Immunol 2003 111 : 1087 1094.
121. Lopez CB, Kalergis AM, Becker MI, Garbarino JA, De Ioannes AE. CD8+ T cells are the effectors of the contact dermatitis induced by urushiol in mice and are regulated by CD4+ T cells. Int Arch Allergy Immunol 1998 117 : 194 201.
122. Cavani A, Albanesi C, Traidl C, Sebastiani S, Girolomoni G. Effector and regulatory T cells in allergic contact dermatitis. Trends Immunol 2001 22 : 118 120. (Pubitemid 32675251)
123. Martin SF, Dudda JC, Delattre V, Bachtanian E, Leicht C, Burger B et al. Fas-mediated inhibition of CD4+ T cell priming results in dominance of type 1 CD8+ T cells in the immune response to the contact sensitizer trinitrophenyl. J Immunol 2004 173 : 3178 3185.
124. Albanesi C, Cavani A, Girolomoni G. IL-17 is produced by nickel-specific T lymphocytes and regulates ICAM-1 expression and chemokine production in human keratinocytes: synergistic or antagonist effects with IFN-gamma and TNF-alpha. J Immunol 1999 162 : 494 502.
125. Albanesi C, Scarponi C, Cavani A, Federici M, Nasorri F, Girolomoni G. Interleukin-17 is produced by both Th1 and Th2 lymphocytes, and modulates interferon-gamma- and interleukin-4-induced activation of human keratinocytes. J Invest Dermatol 2000 115 : 81 87.
126. Nakae S, Komiyama Y, Nambu A, Sudo K, Iwase M, Homma I et al. Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses. Immunity 2002 17 : 375 387.
127. Wakabayashi T, Hu DL, Tagawa Y, Sekikawa K, Iwakura Y, Hanada K et al. IFN-gamma and TNF-alpha are involved in urushiol-induced contact hypersensitivity in mice. Immunol Cell Biol 2005 83 : 18 24.
128. Traidl C, Sebastiani S, Albanesi C, Merk HF, Puddu P, Girolomoni G et al. Disparate cytotoxic activity of nickel-specific CD8+ and CD4+ T cell subsets against keratinocytes. J Immunol 2000 165 : 3058 3064.
129. Trautmann A, Akdis M, Schmid-Grendelmeier P, Disch R, Brocker EB, Blaser K et al. Targeting keratinocyte apoptosis in the treatment of atopic dermatitis and allergic contact dermatitis. J Allergy Clin Immunol 2001 108 : 839 846. (Pubitemid 33096219)
130. Kalish RS, Wood JA, LaPorte A. Processing of urushiol (poison ivy) hapten by both endogenous and exogenous pathways for presentation to T cells in vitro. J Clin Invest 1994 93 : 2039 2047.
131. Takeshita K, Yamasaki T, Akira S, Gantner F, Bacon KB. Essential role of MHC II-independent CD4+ T cells, IL-4 and STAT6 in contact hypersensitivity induced by fluorescein isothiocyanate in the mouse. Int Immunol 2004 16 : 685 695.
132. Yokozeki H, Watanabe K, Igawa K, Miyazaki Y, Katayama I, Nishioka K. Gammadelta T cells assist alphabeta T cells in the adoptive transfer of contact hypersensitivity to para-phenylenediamine. Clin Exp Immunol 2001 125 : 351 359.
133. O'Leary JG, Goodarzi M, Drayton DL, von Andrian UH. T cell- and B cell-independent adaptive immunity mediated by natural killer cells. Nat Immunol 2006 7 : 507 516.
134. Gainers ME, Descheny L, Barthel SR, Liu L, Wurbel MA, Dimitroff CJ. Skin-homing receptors on effector leukocytes are differentially sensitive to glyco-metabolic antagonism in allergic contact dermatitis. J Immunol 2007 179 : 8509 8518.
135. Yang J, Huck SP, McHugh RS, Hermans IF, Ronchese F. Perforin-dependent elimination of dendritic cells regulates the expansion of antigen-specific CD8+ T cells in vivo. Proc Natl Acad Sci USA 2006 103 : 147 152.
136. Lebbink RJ, Meyaard L. Non-MHC ligands for inhibitory immune receptors: novel insights and implications for immune regulation. Mol Immunol 2007 44 : 2153 2164.
137. Keir ME, Butte MJ, Freeman GJ, Sharpe AH. PD-1 and its ligands in tolerance and immunity. Annu Rev Immunol 2008 26 : 677 704.
138. Loser K, Mehling A, Loeser S, Apelt J, Kuhn A, Grabbe S et al. Epidermal RANKL controls regulatory T-cell numbers via activation of dendritic cells. Nat Med 2006 12 : 1372 1379.
139. Cavani A, De Pita O, Girolomoni G. New aspects of the molecular basis of contact allergy. Curr Opin Allergy Clin Immunol 2007 7 : 404 408.
140. Meng X, Sawamura D, Tamai K, Hanada K, Ishida H, Hashimoto I. Keratinocyte gene therapy for systemic diseases. J Clin Invest 1998 101 : 1462 1467.
141. Enk AH, Katz SI. Contact sensitivity as a model for T-cell activation in skin. J Invest Dermatol 1995 105 (1 SUPPL. 80S 83S.
142. O'Garra A, Vieira P. Regulatory T cells and mechanisms of immune system control. Nat Med 2004 10 : 801 805.
143. Grimbaldeston MA, Nakae S, Kalesnikoff J, Tsai M, Galli SJ. Mast cell-derived interleukin 10 limits skin pathology in contact dermatitis and chronic irradiation with ultraviolet B. Nat Immunol 2007 8 : 1095 1104.
144. Cavani A, Ottaviani C, Nasorri F, Sebastiani S, Girolomoni G. Immunoregulation of hapten and drug induced immune reactions. Curr Opin Allergy Clin Immunol 2003 3 : 243 247.
145. Melrose J, Tsurushita N, Liu G, Berg EL. IFN-gamma inhibits activation-induced expression of E- and P-selectin on endothelial cells. J Immunol 1998 161 : 2457 2464.
146. Shevach EM. From vanilla to 28 flavors: multiple varieties of T regulatory cells. Immunity 2006 25 : 195 201.
147. Gorbachev AV, Fairchild RL. Induction and regulation of T-cell priming for contact hypersensitivity. Crit Rev Immunol 2001 21 : 451 472.
148. Sakaguchi S, Ono M, Setoguchi R, Yagi H, Hori S, Fehervari Z et al. Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunol Rev 2006 212 : 8 27.
149. Kretschmer K, Apostolou I, Hawiger D, Khazaie K, Nussenzweig MC, von Boehmer H. Inducing and expanding regulatory T cell populations by foreign antigen. Nat Immunol 2005 6 : 1219 1227.
150. Dubois B, Chapat L, Goubier A, Papiernik M, Nicolas JF, Kaiserlian D. Innate CD4+CD25+ regulatory T cells are required for oral tolerance and inhibition of CD8+ T cells mediating skin inflammation. Blood 2003 102 : 3295 3301.
151. Ruckert R, Brandt K, Hofmann U, Bulfone-Paus S, Paus R. IL-2-IgG2b fusion protein suppresses murine contact hypersensitivity in vivo. J Invest Dermatol 2002 119 : 370 376.
152. Ring S, Schafer SC, Mahnke K, Lehr HA, Enk AH. CD4+ CD25+ regulatory T cells suppress contact hypersensitivity reactions by blocking influx of effector T cells into inflamed tissue. Eur J Immunol 2006 36 : 2981 2992.
153. Maeda A, Beissert S, Schwarz T, Schwarz A. Phenotypic and functional characterization of ultraviolet radiation-induced regulatory T cells. J Immunol 2008 180 : 3065 3071.
154. Cavani A, Nasorri F, Ottaviani C, Sebastiani S, De Pita O, Girolomoni G. Human CD25+ regulatory T cells maintain immune tolerance to nickel in healthy, nonallergic individuals. J Immunol 2003 171 : 5760 5768.
155. O'Garra A, Vieira P. T(H)1 cells control themselves by producing interleukin-10. Nat Rev Immunol 2007 7 : 425 428.
156. Maurer M, Seidel-Guyenot W, Metz M, Knop J, Steinbrink K. Critical role of IL-10 in the induction of low zone tolerance to contact allergens. J Clin Invest 2003 112 : 432 439.
157. Yanaba K, Bouaziz JD, Haas KM, Poe JC, Fujimoto M, Tedder TF. A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses. Immunity 2008 28 : 639 650.
158. Girardi M, Lewis J, Glusac E, Filler RB, Geng L, Hayday AC et al. Resident skin-specific gammadelta T cells provide local, nonredundant regulation of cutaneous inflammation. J Exp Med 2002 195 : 855 867.
159. Vocanson M, Hennino A, Chavagnac C, Rozieres A, Saint-Mezard P, Akiba H et al. Allergic contact dermatitis: how to re-induce tolerance? Med Sci (Paris) 2006 22 : 158 163.